Debiotech of Switzerland, AWAK of Singapore, and Neokidney Development, an initiative of the Dutch Kidney Foundation, have signed a joint venture agreement to develop a miniaturized home hemodialysis machine. This new system will be based on Debiotech's miniaturized peritoneal dialysis equipment DialEase, and AWAK's novel sorbent technology for fluid purification. Neokidney Development will provide access to the Dutch Kidney Foundation's medical expertise and network of internationally acclaimed nephrologists and patient organizations, and will mobilize funding from public and private sources, including health insurers and social impact investors, according to a news release.
The partners said they have committed to complete a functional model in 2015. Clinical trials are planned for 2017. Debiotech and AWAK announced a partnership to develop the device in November 2013.